Trial intelligence / Profile preview

Remimazolam vs propofol for induction and maintenance of general anesthesia in elective surgery

CTR20181376Phase 2Completed

Sponsor
Yichang Humanwell Pharmaceutical Co., Ltd.
Start
Sep 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of remimazolam, sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Sep 2018; status: completed.

02

Drugs

remimazolam

Beyond the preview

Go deeper on CTR20181376.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20181376.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call